Outcomes
type 2 diabetes mellitus, Diabetes
TYPE 2 DIABETES MELLITUS, DIABETES
Alongside demographic questions, the first primary endpoint was to evaluate the QoL of type 2 diabetes mellitus patients receiving Treviamet® & Treviamet XR® (Sitagliptin with Metformin)using Diabetes Quality of Life assessment using DQoL-13 interview-based questionnaire [The DQoL questionnaire is a 13-item scale including three domains satisfaction (6 items), impact (4 items), and worry (3 items). The range of scores for each item is 1 to 5, where 1 denotes never, 2 very seldom, 3 sometimes, 4 often, and 5 denotes all the time [